These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Thrombin generation as an intermediate phenotype for venous thrombosis. Segers O; van Oerle Rv; ten Cate Ht; Rosing J; Castoldi E Thromb Haemost; 2010 Jan; 103(1):114-22. PubMed ID: 20062924 [TBL] [Abstract][Full Text] [Related]
4. Anticoagulants and the propagation phase of thrombin generation. Orfeo T; Gissel M; Butenas S; Undas A; Brummel-Ziedins KE; Mann KG PLoS One; 2011; 6(11):e27852. PubMed ID: 22125631 [TBL] [Abstract][Full Text] [Related]
5. Factor Xa generation by computational modeling: an additional discriminator to thrombin generation evaluation. Brummel-Ziedins KE; Orfeo T; Gissel M; Mann KG; Rosendaal FR PLoS One; 2012; 7(1):e29178. PubMed ID: 22247769 [TBL] [Abstract][Full Text] [Related]
6. Platelets and phospholipids in tissue factor-initiated thrombin generation. Butenas S; Branda RF; van't Veer C; Cawthern KM; Mann KG Thromb Haemost; 2001 Aug; 86(2):660-7. PubMed ID: 11522019 [TBL] [Abstract][Full Text] [Related]
7. Defining the boundaries of normal thrombin generation: investigations into hemostasis. Danforth CM; Orfeo T; Everse SJ; Mann KG; Brummel-Ziedins KE PLoS One; 2012; 7(2):e30385. PubMed ID: 22319567 [TBL] [Abstract][Full Text] [Related]
8. Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis. Sinha U; Ku P; Malinowski J; Zhu BY; Scarborough RM; Marlowe CK; Wong PW; Lin PH; Hollenbach SJ Eur J Pharmacol; 2000 Apr; 395(1):51-9. PubMed ID: 10781674 [TBL] [Abstract][Full Text] [Related]
9. Flow-simulated thrombin generation profiles as a predictor of thrombotic risk among pre-menopausal women. Jordan SW; Corriere MA; Vossen CY; Rosendaal FR; Chaikof EL Thromb Haemost; 2012 Aug; 108(2):258-65. PubMed ID: 22688389 [TBL] [Abstract][Full Text] [Related]
10. Enhanced thrombin generation and reduced intact protein S in processed solvent detergent plasma. Pitkänen H; Jouppila A; Mowinckel MC; Lemponen M; Patiwael S; Sandset PM; Lassila R; Brinkman HJ Thromb Res; 2015 Jan; 135(1):167-74. PubMed ID: 25466844 [TBL] [Abstract][Full Text] [Related]
11. Effect of oral contraceptives on the anticoagulant activity of protein S in plasma. Koenen RR; Christella M; Thomassen LG; Tans G; Rosing J; Hackeng TM Thromb Haemost; 2005 May; 93(5):853-9. PubMed ID: 15886799 [TBL] [Abstract][Full Text] [Related]
12. Preserved clot formation detected by the Thrombodynamics analyzer in patients with cirrhosis. Potze W; Adelmeijer J; Porte RJ; Lisman T Thromb Res; 2015 May; 135(5):1012-6. PubMed ID: 25746364 [TBL] [Abstract][Full Text] [Related]
13. Thrombin generation in patients after acute deep-vein thrombosis. ten Cate-Hoek AJ; Dielis AW; Spronk HM; van Oerle R; Hamulyák K; Prins MH; ten Cate H Thromb Haemost; 2008 Aug; 100(2):240-5. PubMed ID: 18690343 [TBL] [Abstract][Full Text] [Related]
14. Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence. van Hylckama Vlieg A; Christiansen SC; Luddington R; Cannegieter SC; Rosendaal FR; Baglin TP Br J Haematol; 2007 Sep; 138(6):769-74. PubMed ID: 17760809 [TBL] [Abstract][Full Text] [Related]
15. The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study. van Hylckama Vlieg A; Baglin CA; Luddington R; MacDonald S; Rosendaal FR; Baglin TP J Thromb Haemost; 2015 Sep; 13(9):1642-52. PubMed ID: 26178257 [TBL] [Abstract][Full Text] [Related]
16. Impaired thrombin generation in Reelin-deficient mice: a potential role of plasma Reelin in hemostasis. Tseng WL; Chen TH; Huang CC; Huang YH; Yeh CF; Tsai HJ; Lee HY; Kao CY; Lin SW; Liao HR; Cheng JC; Tseng CP J Thromb Haemost; 2014 Dec; 12(12):2054-64. PubMed ID: 25255925 [TBL] [Abstract][Full Text] [Related]
17. In vitro assessment, using thrombin generation, of the applicability of prothrombin complex concentrate as an antidote for Rivaroxaban. Dinkelaar J; Molenaar PJ; Ninivaggi M; de Laat B; Brinkman HJ; Leyte A J Thromb Haemost; 2013 Jun; 11(6):1111-8. PubMed ID: 23578206 [TBL] [Abstract][Full Text] [Related]
18. Enhanced thrombin generation in women with a history of oral contraception-related venous thrombosis. Anžej Doma S; Vučnik M; Božič Mijovski M; Peternel P; Stegnar M Thromb Res; 2013 Nov; 132(5):621-6. PubMed ID: 24083963 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the capacities of two prothrombin complex concentrates to restore thrombin generation in plasma from orally anticoagulated patients: an in vitro study. Dargaud Y; Desmurs-Clavel H; Marin S; Bordet JC; Poplavsky JL; Negrier C J Thromb Haemost; 2008 Jun; 6(6):962-8. PubMed ID: 18373620 [TBL] [Abstract][Full Text] [Related]
20. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study. Middeldorp S; Meijers JC; van den Ende AE; van Enk A; Bouma BN; Tans G; Rosing J; Prins MH; Büller HR Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]